To ensure clinical and translational cancer research is reliable and reproducible, it is essential to have access to human biological materials in sufficient quality and quantity, and linked to high-quality clinical data. EORTC studies comply with all applicable ethical, legal and quality assurance requirements regarding the collection of human biological materials, in accordance with EORTC’s Human Biological Material Collection, Storage and Use policy.